Shares of the nation’s three largest telecom providers jumped on Monday after they integrated ... the stock to Buy from Hold with a $150 price target. McDonald’s (MCD), Vertex (VRTX), Arch Capital ...

Blink Ops, the AI security automation platform, today announced record growth marked by 400% increase in year-over-year ...

The stock market showed resilience after Monday's DeepSeek-spurred sell-off in AI hardware stocks. Apple, Tesla, Microsoft led big earnings.

The FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.

Vertex Minerals has initiated the commissioning of a newly installed ore sorter at its Hill End Gold plant in Australia.

The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...

The FDA recently approved Journavx for treating acute pain. This approval is tremendously important for Vertex Pharmaceuticals. The biotech company has also received other good news over the last ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

Vertex will charge $15.50 a pill for Journavx, or $217 for a week’s prescription. (/Associated Press) Shares of Vertex Pharmaceuticals gained about 6% Friday morning, after the pharmaceutical ...

BOSTON, January 12, 2025--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the ...